Description

Methyl 4-[(8,9-Dimethoxy-2-Oxo-2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)Sulfanyl]Butanoate is a high-purity synthetic organic compound, identified by CAS number 672949-43-8, serving as a critical advanced intermediate in pharmaceutical research and development. Its complex heterocyclic structure makes it a valuable building block for creating novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas targeting specific enzymatic pathways. This compound is essential for medicinal chemists and process development scientists in the pharmaceutical and biotechnology industries who require reliable, high-quality intermediates for drug discovery and scale-up.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly for oncology and central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize the potency and selectivity of lead compounds.
• Process Chemistry & Scale-Up: Serves as a defined intermediate in the development and optimization of scalable synthetic routes for Active Pharmaceutical Ingredients (APIs).
• Biochemical Tool Compound: Potential use in biochemical assays as a probe or inhibitor to study specific biological targets and pathways.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of specialized, non-commercial drug substances.

Basic Information

Product Name	Methyl 4-[(8,9-Dimethoxy-2-Oxo-2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)Sulfanyl]Butanoate
CAS No.	672949-43-8
Molecular Formula	C₁₇H₁₇N₃O₅S
Molecular Weight	375.40 g/mol
Synonyms	Methyl 4-((8,9-dimethoxy-2-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio)butanoate; 5-[(3-Methoxycarbonylpropyl)thio]-8,9-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-2-one; Butanoic acid, 4-[(8,9-dimethoxy-2-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]-, methyl ester; CAS 672949-43-8
EINECS	Contact for details

Quality Control

Our production of Methyl 4-[(8,9-Dimethoxy-2-Oxo-2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)Sulfanyl]Butanoate adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. A Certificate of Analysis (COA) detailing all specifications and test results is provided with each shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed and under an inert atmosphere (e.g., nitrogen or argon) for long-term storage to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.